Galmed Pharmaceuticals Ltd. - Ordinary Shares (NQ:GLMD)
1.590
-0.090
(-5.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2025
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
MarketBeat Week in Review – 9/16 - 9/20
September 21, 2024
Galmed Pharmaceuticals Stock Is Soaring Thursday: Here's Why
September 19, 2024
US Stocks Mixed; General Mills Posts Upbeat Earnings
September 18, 2024
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?
September 17, 2024
Gold Edges Lower; US Homebuilder Sentiment Rises For September
September 17, 2024
Crude Oil Gains Over 1%; US Business Inventories Increase In July
September 17, 2024
Nasdaq Surges 100 Points; US Retail Sales Beat Estimates
September 17, 2024
Frequently Asked QuestionsIs Galmed Pharmaceuticals Ltd. - Ordinary Shares publicly traded?
Yes, Galmed Pharmaceuticals Ltd. - Ordinary Shares is publicly traded.
What exchange does Galmed Pharmaceuticals Ltd. - Ordinary Shares trade on?
Galmed Pharmaceuticals Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Galmed Pharmaceuticals Ltd. - Ordinary Shares?
The ticker symbol for Galmed Pharmaceuticals Ltd. - Ordinary Shares is GLMD on the Nasdaq Stock Market
What is the current price of Galmed Pharmaceuticals Ltd. - Ordinary Shares?
The current price of Galmed Pharmaceuticals Ltd. - Ordinary Shares is 1.590
When was Galmed Pharmaceuticals Ltd. - Ordinary Shares last traded?
The last trade of Galmed Pharmaceuticals Ltd. - Ordinary Shares was at 03/28/25 04:00 PM ET
What is the market capitalization of Galmed Pharmaceuticals Ltd. - Ordinary Shares?
The market capitalization of Galmed Pharmaceuticals Ltd. - Ordinary Shares is 10.11M
How many shares of Galmed Pharmaceuticals Ltd. - Ordinary Shares are outstanding?
Galmed Pharmaceuticals Ltd. - Ordinary Shares has 10M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|